Is value investing dead?

Is growth investing the best way to make a fortune in the share market?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The above topic is one of the biggest questions across stock markets right now as the popular 'value investing' approach taught by Ben Graham and passed on by Warren Buffett has generally been the 'wrong' approach when it comes to beating the market since the GFC.

Ben Graham-style value investing has three core principles in that you should buy stocks that are cheap relative to your assessment of intrinsic value, you should allow a 'margin of safety' in buying stocks below your valuation, and you should not let swings in market sentiment guide you into making investment decisions. In other words you should make the market your servant, not your master.

A lot of professional fund managers follow Graham's principles in avoiding businesses on high price-to-earnings multiples or with no earnings (profits) at all. Instead they look for 'value' stocks at a discount to their intrinsic value. Why they are financially incentivised to take this approach is for another article.

However, what matters is that the approach has lead to sub-standard returns in many cases over the past 10 years, while the alternative approach of buying companies growing revenues at super-strong rates, but perhaps losing money has been a market thumper.

Just consider examples like NetflixAmazon, Shopify, Salesforce and Square in the U.S, while in Australia three of the best performing businesses on the local market over the last few years in Appen Ltd (ASX: APX) (up 4,200%), AfterPay Touch (ASX: APT) (up 500%+) and Pro Medicus Limited (ASX: PME) (up 2,400%) make losses or minuscule profits versus their valuations.

Moreover, all of the aforementioned businesses have been regularly derided as 'too expensive' or 'overvalued" by professional investors and commentators in the business media over the past 10 years, but not buying them has been an expensive blunder.

In fairness if you use conventional valuation metrics taught by Ben Graham or on university courses globally then 'overvalued' would be a logical conclusion.

However, there's a couple of points to understand when assessing whether some businesses are good value today or not.

First up is the ultra-low-interest rate environment since the GFC that is a symptom of very low inflation and wages growth.

In this unusual environment assets that are expected to grow their free cash flows at strong rates long into the future are worth more than they would be in an environment where risk free rates and inflation were higher.

Given the outlook in Australia is for rates to go even lower to virtual ZIRP (zero interest rate policy), it's not hard to see why popular growth stocks like WiseTech Global (ASX: WTC) and Xero Limited (ASX: XRO) continue to rise.

Another point is that the internet has delivered structural change and allowed some companies to establish the kind of dominant global market positions, scalability, and profitability that mean old metrics for assessing value are no longer relevant.

In other words just as the Romans learned to build straight roads largely oblivious to the possibilities of air travel, Ben Graham and university teachers taught value investing metrics largely oblivious to the possibilities of online connectivity.

a woman

So what's an investor to do?

The answer isn't to recklessly buy high-flying internet businesses, but to consider that 'growth' and 'value' are indivisible as both are a function of a future returns.

The big risk with 'value' investing is that you fall into the trap of buying 'non-investment-grade' or low-quality companies because they look 'cheap'.

Buying low-quality companies is probably the commonest investing mistake of all made at least once by every share market participant.

It is possible to make money on low-quality companies if you time your purchase well, or hold for the long term, but buying them in the first place is generally a dumb idea to me.

At the end of the day the quality of a company's business model, balance sheet, competitive position, and top or bottom line growth is what will lead investors to bid shares consistently higher over the long term, which is why the likes of Amazon, Salesforce, Visa, MasterCard and Xero have thumped the market over the last decade and left some value investing metrics in the dust.

Going forward it will probably remain a costly mistake to exclude growth businesses on the basis of insufficient profitability.

Tom Richardson owns shares of AFTERPAY T FPO, Appen Ltd, Pro Medicus Ltd., WiseTech Global, Xero, Visa and Amazon. You can find Tom on Twitter @tommyr345 The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Pro Medicus Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of WiseTech Global. The Motley Fool Australia owns shares of AFTERPAY T FPO, Appen Ltd, and Xero. The Motley Fool Australia has recommended Pro Medicus Ltd. Please note The Motley Fool Australia's parent company also may recommend and own all of the securities mentioned above. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the week for investors this Friday.

Read more »

Woman thinking in a supermarket.
Dividend Investing

Coles stock vs Woolworths shares: Who had the better dividend this week?

Let's check the receipts on Coles and Woolies this week.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »

ASX board.
ASX Share Market News

Why the ASX 200 is pushing higher as rate hike fears grow

Tech stocks are leading the market rebound today.

Read more »

Small kid giving a thumbs up.
Broker Notes

9 ASX 200 shares with strengthened buy ratings this week

Brokers are positive on Paladin Energy, Coles, WiseTech, Centuria Capital, and other shares.

Read more »